Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 12/20 | 0.90 |
| ▸ | MMP8 | P22894 | 4/20 | 0.90 |
| ▸ | MMP1 | P03956 | 7/20 | 0.59 |
| ▸ | MMP3 | P08254 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7076532 | 0.95 | MMP13 (1.00) | MMP13MMP8MMP1MMP3HTT | |
| SCHEMBL7212113 | 0.87 | MMP13 (0.80) | MMP13MMP8MMP1MMP3HTT | |
| SCHEMBL14379753 | 0.84 | MMP13 (0.70) | MMP13MMP8MMP1HTTNPSR1 | |
| SCHEMBL24175871 | 0.83 | MMP13 (0.68) | MMP13MMP8MMP1MMP3HTT | |
| SCHEMBL7213584 | 0.83 | MMP13 (0.68) | MMP13MMP8MMP1HTTNPSR1 | |
| SCHEMBL24175875 | 0.83 | MMP13 (0.68) | MMP13MMP8MMP1MMP3HTT | |
| SCHEMBL20054093 | 0.82 | MMP13 (0.72) | MMP13MMP8MMP1HTTNPSR1 | |
| SCHEMBL10569165 | 0.81 | MMP13 (0.66) | MMP13MMP8MMP1HTTNPSR1 | |
| SCHEMBL7082733 | 0.81 | MMP13 (0.70) | MMP13MMP8MMP1HTTNPSR1 | |
| SCHEMBL10570690 | 0.81 | MMP13 (0.70) | MMP13MMP8MMP1HTTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0939628-B1 | THIOL SULFONE METALLOPROTEASE INHIBITORS | MONSANTO CO (US) | 2003-03-05 | — | — | EP | disclosed |
| US-6013649-A | BOND DISORDERS; AUTOIMMUNE DISEASES; ANTITUMOR AGENTS | MONSANTO COMPANY (US) | 2000-01-11 | — | — | US | disclosed |
| EP-0939628-A4 | THIOL SULFONE METALLOPROTEASE INHIBITORS | MONSANTO CO (US) | 1999-12-22 | — | — | EP | disclosed |
| EP-0939628-A1 | THIOL SULFONE METALLOPROTEASE INHIBITORS | MONSANTO COMPANY (US) | 1999-09-08 | — | — | EP | disclosed |
| WO-1998003164-A1 | THIOL SULFONE METALLOPROTEASE INHIBITORS | MONSANTO COMPANY (US) | 1998-01-29 | — | — | WO | disclosed |